News

The vaccine maker’s board intends to recommend a pending offer from investment firms Nordic Capital and Permira, which would take over the drugmaker and delist it from market.
Amid a new strain of mpox, the Danish company is preparing to make millions of vaccine doses to supply to the world.
The directors of the vaccine maker said the offer from Permira and Nordic Capital was an attractive proposal and recommended that shareholders accept it.
COPENHAGEN, Denmark, July 31, 2025 - Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the sale of its ...
After what Bavarian Nordic described as “intense negotiations,” the Danish vaccine maker has agreed to be acquired by a private equity consortium in a 19 billion krone ($3 billion) deal.
Shares in Bavarian Nordic - one of the few drug firms with an mpox vaccine - were up about 19% since market close on Aug. 13, the day before the WHO announcement.
Employees of a Bavarian Nordic factory near Munich, Germany, are under pressure to produce more monkeypox vaccine doses as cases across the globe break 40,000, including a handful of deaths.
Bavarian Nordic’s stock soared 10% on Thursday after the Danish biotech company posted better-than-expected second-quarter earnings and unveiled an order for 440,000 doses of smallpox and mpox ...
Danish biotechnology company Bavarian Nordic, the only producer of a vaccine approved against monkeypox, has been approached by many countries keen on procuring vaccines against the disease which ...
Danish biotech firm Bavarian Nordic said on Tuesday it will donate 40,000 doses of its mpox vaccine to Africa's top public health body, after the body declared an emergency.
BAVARIAN NORDIC (BVNRY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...
Vaccine maker Bavarian Nordic on Monday said it has agreed in principle to a roughly $3 billion take-private offer from private equity firms Nordic Capital and Permira.